Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201

Completed

Conditions studied: Macular Edema, Retinal Vein Occlusion

In brief

The purpose of this non interventional retrospective study is to continue to collect data from patients following their completion of Protocol CLS 1003-201: "Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept in Subjects with Macular Edema Following Retinal Vein Occlusion" (ie, the parent study).

Key facts

Study ID

NCT02956330

Run by

Clearside Biomedical, Inc.

People needed

20

Starts

2016-11-01

Expected to finish

2017-04-12

Last updated by the study team

2019-12-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed enrollment and did not receive additional aflibercept therapy in the Parent study, CLS1003-201

You may not qualify if…

• N/A

Where it is running

• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.